Incyte was granted a patent for an antibody and T-cell cancer therapy.

{
  "signal_id": "85611c75-0041-56ce-934b-d9ee615083db",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-30T16:58:59+00:00",
  "company": {
    "name": "Incyte",
    "domain": "incyte.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C07K 16/2803"
      },
      {
        "code": "A61K 40/11"
      },
      {
        "code": "A61K 40/32"
      },
      {
        "code": "A61K 40/42"
      },
      {
        "code": "A61K 2239/48"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Medical Research"
    ],
    "detail": "In September 2026 Incyte patented a combination treatment for leukemia and lymphoma, pairing CD19-targeting antibodies with gamma delta T-cells.",
    "summary": "Incyte was granted a patent for an antibody and T-cell cancer therapy.",
    "event_at": "2026-09-29",
    "inventors": [
      {
        "name": "Jan Endell",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Rainer Boxhammer",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/rainer-boxhammer-5503b4167"
      },
      {
        "name": "Dominik Pretscher",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-29",
    "source_url": "https://patents.google.com/patent/US12747292",
    "cpc_primary": {
      "code": "C07K 16/2803"
    },
    "patent_title": "Anti-tumor combination therapy comprising anti-CD19 antibody and gamma delta T-cells",
    "patent_number": "US12747292",
    "uspto_assignee": "Incyte Corporation",
    "patent_abstract": "The present disclosure is directed to a combination therapy comprising an anti-CD19 antibody or antibody fragment thereof and gamma delta T-cells (γδ T-cells) for use in the treatment of leukemia or lymphoma.",
    "precision_class": "structural",
    "invention_explanation": "A cancer treatment that combines antibodies aimed at CD19 on tumor cells with gamma delta immune cells to help attack leukemia or lymphoma.",
    "technologies_mentioned": [
      "immunotherapy",
      "antibody therapy",
      "gamma delta T-cells",
      "oncology"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/85611c75-0041-56ce-934b-d9ee615083db \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"incyte.com","limit":20}'